BridgeMD
New treatment option for Post Operative Pain
Official title Assessing the Impact of Additional Serratus Anterior Block Within 24-Hour on Postoperative Pain After Rhomboid Intercostal Block in VATS Patients
ClinicalTrials.gov ID: NCT06838039
What this study is testing
- What it's testing
- Title: Assessing the Impact of Additional Serratus Anterior Block on Postoperative Pain After Rhomboid Intercostal Block in VATS Patients Purpose: This randomized controlled trial aims to evaluate whether the addition of a Serratus Anterior Plane Block (SAPB) to the standard Rhomboid Intercostal Block (RIB) improves postoperative pain management in patients undergoing Video-Assisted Thoracoscopic Surgery (VATS). Study Design: Type: Randomized Controlled Trial (RCT) Participants: 50 patients aged 18 -70 requiring VATS, randomized into two groups: one receiving RIB alone, and the other receiving RIB + SAPB.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Adults aged 18-70 years.
- Patients undergoing Video-Assisted Thoracoscopic Surgery (VATS).
- Classified as ASA physical status I-III (low to moderate surgical risk).
- Ability to provide informed consent and follow study protocols.
You likely can't join if
- Known allergy or hypersensitivity to local anesthetics.
- Presence of bleeding disorders or anticoagulant use.
- History of chronic opioid use or opioid dependence.
- Anatomical abnormalities or conditions preventing the application of regional anesthesia (e.g., chest wall deformities).
- Presence of neurological disorders affecting pain perception.
- Cognitive impairments, language barriers, or inability to communicate effectively.
See the full eligibility criteria
- Adults aged 18-70 years.
- Patients undergoing Video-Assisted Thoracoscopic Surgery (VATS).
- Classified as ASA physical status I-III (low to moderate surgical risk).
- Ability to provide informed consent and follow study protocols.
- Known allergy or hypersensitivity to local anesthetics.
- Presence of bleeding disorders or anticoagulant use.
- History of chronic opioid use or opioid dependence.
- Anatomical abnormalities or conditions preventing the application of regional anesthesia (e.g., chest wall deformities).
- Presence of neurological disorders affecting pain perception.
- Cognitive impairments, language barriers, or inability to communicate effectively.
- Pregnancy or breastfeeding.
- Refusal or inability to provide informed consent.
The study team makes the final eligibility decision.
Where it's taking place
- Hebron, Palestinian Territories
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hebron, Palestinian Territories. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.